Company news
Oxford Nanopore Technologies PLC news in 2023
Oxford Nanopore Technologies PLC's news releases, calls and decks from 2023, newest first.
Appointment of Two Non-Executive Directors
December 19, 2023
Nanopore Community Meeting Technology Update
December 7, 2023
National Australian rare disease programme
November 30, 2023
Participation in upcoming investor conferences
November 13, 2023
Apple showcases Oxford Nanopore in M3 launch
October 31, 2023
Mayo Clinic and Oxford Nanopore collaboration
October 19, 2023
Capital Markets Day - ONT expands into clinical
October 19, 2023
bioMérieux makes investment in Oxford Nanopore
October 19, 2023
Presentation at the Morgan Stanley Conference
September 12, 2023
Interim results for the 6 months ended 30 June 23
September 6, 2023
Notice of Results and Capital Markets Day
August 25, 2023
Kate Priestman appointed as Non-Executive Director
July 13, 2023
National German rare disease study
June 12, 2023
Change of Broker
June 9, 2023
Next step of PathoQuest strategic collaboration
May 12, 2023
Director/PDMR Notification
May 4, 2023
New infectious disease partnership with bioMerieux
April 17, 2023
Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
April 14, 2023
NIH Alzheimers study shows scaled, accurate data
April 11, 2023
NIHR, Oxford Nanopore announce new health study
March 31, 2023
Final results for the year ended 31 December 2022
March 21, 2023
Notice of Results
March 9, 2023
Changes to Director Roles and Responsibilities
February 27, 2023
Total Voting Rights and Issue of Equity
February 1, 2023
Trading update
January 17, 2023
Issue of equity and Total Voting Rights
January 3, 2023
Decks in 2023
- Investor Day (October 2023)
Investor day · 171 slides · Oct 19, 2023
- H1 2023 Earnings Presentation
Earnings · 36 slides · Sep 6, 2023
- FY2022 Earnings Presentation
Earnings · 38 slides · Mar 21, 2023